HIGHLIGHTS
- who: Mojca Jensterle and collaborators from the Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center have published the research: Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives, in the Journal: Biomedicines 2022, 10, 1989. of 15/06/2022
- what: In the present narrative review the authors explore the current clinical evidence and provide the future perspectives and challenges for their implementation in PCOS management. Although the study was not designed to investigate the underlying mechanisms of this difference in the reproductive outcome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.